We are live on ! Find out more
SCM

Spyglass Capital Management Portfolio holdings

AUM $1.41B
1-Year Est. Return 7.96%
This Fund
S&P 500
This Quarter Est. Return
+24.03%
1 Year Est. Return
+7.96%
3 Year Est. Return
+119.41%
5 Year Est. Return
+57.27%
10 Year Est. Return
–
AUM
$1.78B
AUM Growth
+$255M
Cap. Flow
-$33.9M
Cap. Flow %
-1.91%
Top 10 Hldgs %
51.13%
Holding
27
New
2
Increased
15
Reduced
8
Closed
2

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$76.6M
2
MEDP icon
Medpace
MEDP
+$41M
3
CYBR
CyberArk
CYBR
+$35.3M
4
CSGP icon
CoStar Group
CSGP
+$29.6M
5
WSC icon
WillScot Mobile Mini Holdings
WSC
+$19.4M

Top Sells

Rank Stock Value
1
APP icon
Applovin
APP
+$127M
2
ASND icon
Ascendis Pharma A/S
ASND
+$97.5M
3
AFRM icon
Affirm
AFRM
+$35.9M
4
TDG icon
TransDigm Group
TDG
+$34.8M
5
ALAB icon
Astera Labs
ALAB
+$26.4M

Sector Composition

Rank Sector Weight
1 Technology 33.17%
2 Consumer Discretionary 19.88%
3 Healthcare 17.45%
4 Financials 8.97%
5 Communication Services 7.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASND icon
26
Ascendis Pharma A/S
ASND
$16.8B
– –
-652,841
Closed -$97.5M
TDG icon
27
TransDigm Group
TDG
$67.6B
– –
-24,405
Closed -$34.8M
1
2

Similar funds

EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.41B AUM 18.71% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
EA
Efficient Advisors Mason, Ohio $1.41B AUM 13.81% 1-Year Est. Return
IAS
Insigneo Advisory Services Miami, Florida $1.41B AUM 27.46% 1-Year Est. Return
BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
TWM
Tradition Wealth Management Edina, Minnesota $1.41B AUM 19.71% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Spyglass Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Spyglass Capital Management held 27 positions worth $1.78B, up 17% from $1.52B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Spyglass Capital Management's Q4 2024 filing shows 2 new, 15 increased, 8 reduced and 2 closed positions. Its largest new stake was Illumina: 537,716 shares worth $71.9M. The largest sale was Applovin, an estimated $127M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Spyglass Capital Management's largest Q4 2024 buy was Illumina: 537,716 shares worth $71.9M.
  • Spyglass Capital Management added most to Medpace in Q4 2024, an estimated $41M increase.
  • Spyglass Capital Management's biggest Q4 2024 reduction was Applovin, cutting an estimated $127M.
  • Spyglass Capital Management fully exited Ascendis Pharma A/S in Q4 2024, selling an estimated $97.5M.
  • Spyglass Capital Management's ten largest holdings make up 51% of its $1.78B portfolio in Q4 2024.
  • Spyglass Capital Management opened 2 new positions and closed 2 in Q4 2024.
  • Spyglass Capital Management's portfolio value rose 17% quarter-over-quarter to $1.78B.

Based on Spyglass Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.